Multifaceted Role of Insulin-Like Growth Factors and Mammalian Target of Rapamycin in Skeletal Muscle

Endocrinology and Metabolism Clinics of North America

Volumn 41, Issue 2, 2012, Pages 297-322

  Frost, Robert A ^a   Lang, Charles H ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

Insulin like growth factors; Mammalian target of rapamycin; Muscle mass; Skeletal muscle

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; ANDROSTANOLONE; DEXAMETHASONE; FOLLISTATIN; GLUCOCORTICOID; INSULIN; MAMMALIAN TARGET OF RAPAMYCIN; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 1; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 2; MITOGEN ACTIVATED PROTEIN KINASE; MYOSTATIN; PRASTERONE; PROTEIN KINASE B; RAG1 PROTEIN; RAG2 PROTEIN; RHEB PROTEIN; SOMATOMEDIN; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN RECEPTOR;

ANTIINFLAMMATORY ACTIVITY; AUTOPHAGY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME LOCALIZATION; ENZYME PHOSPHORYLATION; HOMEOSTASIS; HORMONE ACTION; HUMAN; HYPERPLASIA; IMMOBILIZATION; MUSCLE ATROPHY; MUSCLE FUNCTION; MUSCLE HYPERTROPHY; MUSCLE MASS; NONHUMAN; PLASTICITY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN SYNTHESIS; PROTEIN TARGETING; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; SKELETAL MUSCLE;

AMINO ACIDS, BRANCHED-CHAIN; ANDROGENS; ANIMALS; EXERCISE; FEMALE; FOLLISTATIN; GLUCOCORTICOIDS; HUMANS; MALE; MICE; MUSCLE, SKELETAL; MUSCULAR ATROPHY; MYOSTATIN; RATS; SOMATOMEDINS; TOR SERINE-THREONINE KINASES;

MAMMALIA;

EID: 84861975535     PISSN: 08898529     EISSN: 15584410     Source Type: Journal    
DOI: 10.1016/j.ecl.2012.04.012     Document Type: Review

References (218)

1. Porter Abate J., Blackwell T.K. Life is short, if sweet. Cell Metab 2009, 10:338.
2. Spanier B., Rubio-Aliaga I., Hu H., et al. Altered signalling from germline to intestine pushes daf-2;pept-1 Caenorhabditis elegans into extreme longevity. Aging Cell 2010, 9:636.
3. Heron-Milhavet L., Mamaeva D., LeRoith D., et al. Impaired muscle regeneration and myoblast differentiation in mice with a muscle-specific KO of IGF-IR. J Cell Physiol 2010, 225:1.
4. Ten Broek R.W., Grefte S., Von den Hoff J.W. Regulatory factors and cell populations involved in skeletal muscle regeneration. J Cell Physiol 2010, 224:7.
5. Liu J.P., Baker J., Perkins A.S., et al. Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r). Cell 1993, 75:59.
6. Liu J.L., LeRoith D. Insulin-like growth factor I is essential for postnatal growth in response to growth hormone. Endocrinology 1999, 140:5178.
7. Mavalli M.D., DiGirolamo D.J., Fan Y., et al. Distinct growth hormone receptor signaling modes regulate skeletal muscle development and insulin sensitivity in mice. J Clin Invest 2010, 120:4007.
8. Clemmons D.R. Role of IGF-I in skeletal muscle mass maintenance. Trends Endocrinol Metab 2009, 20:349.
9. Stratikopoulos E., Szabolcs M., Dragatsis I., et al. The hormonal action of IGF1 in postnatal mouse growth. Proc Natl Acad Sci U S A 2008, 105:19378.
10. Wu Y., Sun H., Yakar S., et al. Elevated levels of insulin-like growth factor (IGF)-I in serum rescue the severe growth retardation of IGF-I null mice. Endocrinology 2009, 150:4395.
11. Han B., Zhu M.J., Ma C., et al. Rat hindlimb unloading down-regulates insulin like growth factor-1 signaling and AMP-activated protein kinase, and leads to severe atrophy of the soleus muscle. Appl Physiol Nutr Metab 2007, 32:1115.
12. Gehrig S.M., Ryall J.G., Schertzer J.D., et al. Insulin-like growth factor-I analogue protects muscles of dystrophic mdx mice from contraction-mediated damage. Exp Physiol 2008, 93:1190.
13. Frost R.A., Lang C.H. Protein kinase B/Akt: a nexus of growth factor and cytokine signaling in determining muscle mass. J Appl Physiol 2007, 103:378.
14. Schakman O., Gilson H., Kalista S., et al. Mechanisms of muscle atrophy induced by glucocorticoids. Horm Res 2009, 72(Suppl 1):36.
15. Inder W.J., Jang C., Obeyesekere V.R., et al. Dexamethasone administration inhibits skeletal muscle expression of the androgen receptor and IGF-1-implications for steroid-induced myopathy. Clin Endocrinol (Oxf) 2010, 73:126.
16. Muscaritoli M., Bossola M., Aversa Z., et al. Prevention and treatment of cancer cachexia: new insights into an old problem. Eur J Cancer 2006, 42:31.
17. Crown A.L., Cottle K., Lightman S.L., et al. What is the role of the insulin-like growth factor system in the pathophysiology of cancer cachexia, and how is it regulated?. Clin Endocrinol (Oxf) 2002, 56:723.
18. Frost R.A., Lang C.H. Regulation of insulin-like growth factor-I in skeletal muscle and muscle cells. Minerva Endocrinol 2003, 28:53.
19. Schertzer J.D., Lynch G.S. Comparative evaluation of IGF-I gene transfer and IGF-I protein administration for enhancing skeletal muscle regeneration after injury. Gene Ther 2006, 13:1657.
20. Demonbreun A.R., Fahrenbach J.P., Deveaux K., et al. Impaired muscle growth and response to insulin-like growth factor 1 in dysferlin-mediated muscular dystrophy. Hum Mol Genet 2011, 20:779.
21. Vinciguerra M., Musaro A., Rosenthal N. Regulation of muscle atrophy in aging and disease. Adv Exp Med Biol 2010, 694:211.
22. Schertzer J.D., Gehrig S.M., Ryall J.G., et al. Modulation of insulin-like growth factor (IGF)-I and IGF-binding protein interactions enhances skeletal muscle regeneration and ameliorates the dystrophic pathology in mdx mice. Am J Pathol 2007, 171:1180.
23. Zdanowicz M.M., Teichberg S. Effects of insulin-like growth factor-1/binding protein-3 complex on muscle atrophy in rats. Exp Biol Med (Maywood) 2003, 228:891.
24. Herndon D.N., Ramzy P.I., DebRoy M.A., et al. Muscle protein catabolism after severe burn: effects of IGF-1/IGFBP-3 treatment. Ann Surg 1999, 229:713.
25. Xu Y., Fang Y., Chen J., et al. Activation of mTOR signaling by novel fluoromethylene phosphonate analogues of phosphatidic acid. Bioorg Med Chem Lett 2004, 14:1461.
26. Long Y.C., Cheng Z., Copps K.D., et al. Insulin receptor substrates Irs1 and Irs2 coordinate skeletal muscle growth and metabolism via the Akt and AMPK pathways. Mol Cell Biol 2011, 31:430.
27. McCarthy J.J., Esser K.A. Anabolic and catabolic pathways regulating skeletal muscle mass. Curr Opin Clin Nutr Metab Care 2010, 13:230.
28. Risson V., Mazelin L., Roceri M., et al. Muscle inactivation of mTOR causes metabolic and dystrophin defects leading to severe myopathy. J Cell Biol 2009, 187:859.
29. Bentzinger C.F., Romanino K., Cloetta D., et al. Skeletal muscle-specific ablation of raptor, but not of rictor, causes metabolic changes and results in muscle dystrophy. Cell Metab 2008, 8:411.
30. Setia S., Sridhar M.G. Changes in GH/IGF-1 axis in intrauterine growth retardation: consequences of fetal programming?. Horm Metab Res 2009, 41:791.
31. Kappeler L., De Magalhaes Filho C., Leneuve P., et al. Early postnatal nutrition determines somatotropic function in mice. Endocrinology 2009, 150:314.
32. Christoforidis A., Maniadaki I., Stanhope R. Growth hormone/insulin-like growth factor-1 axis during puberty. Pediatr Endocrinol Rev 2005, 3:5.
33. Moller N., Vendelbo M.H., Kampmann U., et al. Growth hormone and protein metabolism. Clin Nutr 2009, 28:597.
34. Dreyer H.C., Drummond M.J., Pennings B., et al. Leucine-enriched essential amino acid and carbohydrate ingestion following resistance exercise enhances mTOR signaling and protein synthesis in human muscle. Am J Physiol Endocrinol Metab 2008, 294:E392.
35. Smith G.I., Atherton P., Reeds D.N., et al. Dietary omega-3 fatty acid supplementation increases the rate of muscle protein synthesis in older adults: a randomized controlled trial. Am J Clin Nutr 2011, 93:402.
36. Heron-Milhavet L., Haluzik M., Yakar S., et al. Muscle-specific overexpression of CD36 reverses the insulin resistance and diabetes of MKR mice. Endocrinology 2004, 145:4667.
37. Gingras A.A., White P.J., Chouinard P.Y., et al. Long-chain omega-3 fatty acids regulate bovine whole-body protein metabolism by promoting muscle insulin signalling to the Akt-mTOR-S6K1 pathway and insulin sensitivity. J Physiol 2007, 579:269.
38. Rennie M.J. Exercise- and nutrient-controlled mechanisms involved in maintenance of the musculoskeletal mass. Biochem Soc Trans 2007, 35:1302.
39. Wolfe R.R. Skeletal muscle protein metabolism and resistance exercise. J Nutr 2006, 136:525S.
40. Anthony J.C., Yoshizawa F., Anthony T.G., et al. Leucine stimulates translation initiation in skeletal muscle of postabsorptive rats via a rapamycin-sensitive pathway. J Nutr 2000, 130:2413.
41. de Oliveira C.A., Latorraca M.Q., de Mello M.A., et al. Mechanisms of insulin secretion in malnutrition: modulation by amino acids in rodent models. Amino Acids 2011, 40:1027.
42. Apro W., Blomstrand E. Influence of supplementation with branched-chain amino acids in combination with resistance exercise on p70S6 kinase phosphorylation in resting and exercising human skeletal muscle. Acta Physiol (Oxf) 2010, 200:237.
43. Tzatsos A., Kandror K.V. Nutrients suppress phosphatidylinositol 3-kinase/Akt signaling via raptor-dependent mTOR-mediated insulin receptor substrate 1 phosphorylation. Mol Cell Biol 2006, 26:63.
44. Goodman C.A., Miu M.H., Frey J.W., et al. A phosphatidylinositol 3-kinase/protein kinase B-independent activation of mammalian target of rapamycin signaling is sufficient to induce skeletal muscle hypertrophy. Mol Biol Cell 2010, 21:3258.
45. Long X., Ortiz-Vega S., Lin Y., et al. Rheb binding to mammalian target of rapamycin (mTOR) is regulated by amino acid sufficiency. J Biol Chem 2005, 280:23433.
46. Nicklin P., Bergman P., Zhang B., et al. Bidirectional transport of amino acids regulates mTOR and autophagy. Cell 2009, 136:521.
47. Suryawan A., Davis T.A. Regulation of protein synthesis by amino acids in muscle of neonates. Front Biosci 2011, 16:1445.
48. McDowell H.E., Christie G.R., Stenhouse G., et al. Leucine activates system A amino acid transport in L6 rat skeletal muscle cells. Am J Physiol 1995, 269:C1287.
49. Avruch J., Long X., Ortiz-Vega S., et al. Amino acid regulation of TOR complex 1. Am J Physiol Endocrinol Metab 2009, 296:E592.
50. Sancak Y., Peterson T.R., Shaul Y.D., et al. The Rag GTPases bind raptor and mediate amino acid signaling to mTORC1. Science 2008, 320:1496.
51. Sancak Y., Bar-Peled L., Zoncu R., et al. Ragulator-Rag complex targets mTORC1 to the lysosomal surface and is necessary for its activation by amino acids. Cell 2010, 141:290.
52. Zoncu R., Bar-Peled L., Efeyan A., et al. mTORC1 senses lysosomal amino acids through an insideout mechanism that requires the vacuolar H(+)-ATPase. Science 2011, 334:678.
53. Sagne C., Agulhon C., Ravassard P., et al. Identification and characterization of a lysosomal transporter for small neutral amino acids. Proc Natl Acad Sci U S A 2001, 98:7206.
54. Goberdhan D.C. Intracellular amino acid sensing and mTORC1-regulated growth: new ways to block an old target?. Curr Opin Investig Drugs 2010, 11:1360.
55. Heublein S., Kazi S., Ogmundsdottir M.H., et al. Proton-assisted amino-acid transporters are conserved regulators of proliferation and amino-acid-dependent mTORC1 activation. Oncogene 2010, 29:4068.
56. Zhao J., Brault J.J., Schild A., et al. FoxO3 coordinately activates protein degradation by the autophagic/lysosomal and proteasomal pathways in atrophying muscle cells. Cell Metab 2007, 6:472.
57. Iida R.H., Kanko S., Suga T., et al. Autophagic-lysosomal pathway functions in the masseter and tongue muscles in the klotho mouse, a mouse model for aging. Mol Cell Biochem 2011, 348:89.
58. Bartke A. Long-lived Klotho mice: new insights into the roles of IGF-1 and insulin in aging. Trends Endocrinol Metab 2006, 17:33.
59. Yu L., McPhee C.K., Zheng L., et al. Termination of autophagy and reformation of lysosomes regulated by mTOR. Nature 2010, 465:942.
60. Settembre C., Zoncu R., Medina D.L., et al. A lysosome-to-nucleus signalling mechanism senses and regulates the lysosome via mTOR and TFEB. EMBO J 2012, 31:1095.
61. Saci A., Cantley L.C., Carpenter C.L. Rac1 regulates the activity of mTORC1 and mTORC2 and controls cellular size. Mol Cell 2011, 42:50.
62. Saha A.K., Xu X.J., Lawson E., et al. Downregulation of AMPK accompanies leucine- and glucose-induced increases in protein synthesis and insulin resistance in rat skeletal muscle. Diabetes 2010, 59:2426.
63. Inoki K., Ouyang H., Zhu T., et al. TSC2 integrates Wnt and energy signals via a coordinated phosphorylation by AMPK and GSK3 to regulate cell growth. Cell 2006, 126:955.
64. Avruch J., Lin Y., Long X., et al. Recent advances in the regulation of the TOR pathway by insulin and nutrients. Curr Opin Clin Nutr Metab Care 2005, 8:67.
65. Zheng M., Wang Y.H., Wu X.N., et al. Inactivation of Rheb by PRAK-mediated phosphorylation is essential for energy-depletion-induced suppression of mTORC1. Nat Cell Biol 2011, 13:263.
66. Miyazaki M., McCarthy J.J., Esser K.A. Insulin like growth factor-1-induced phosphorylation and altered distribution of tuberous sclerosis complex (TSC)1/TSC2 in C2C12 myotubes. FEBS J 2010, 277:2180.
67. Wan M., Wu X., Guan K.L., et al. Muscle atrophy in transgenic mice expressing a human TSC1 transgene. FEBS Lett 2006, 580:5621.
68. Avruch J., Hara K., Lin Y., et al. Insulin and amino-acid regulation of mTOR signaling and kinase activity through the Rheb GTPase. Oncogene 2006, 25:6361.
69. Wang X., Proud C.G. mTORC1 signaling: what we still don't know. J Mol Cell Biol 2011, 3(4):206-220.
70. Sun Y., Fang Y., Yoon M.S., et al. Phospholipase D1 is an effector of Rheb in the mTOR pathway. Proc Natl Acad Sci U S A 2008, 105:8286.
71. Zhang C., Wendel A.A., Keogh M.R., et al. Glycerolipid signals alter mTOR complex 2 (mTORC2) to diminish insulin signaling. Proc Natl Acad Sci U S A 2012, 109:1667.
72. Sengupta S., Peterson T.R., Sabatini D.M. Regulation of the mTOR complex 1 pathway by nutrients, growth factors, and stress. Mol Cell 2010, 40:310.
73. Fang Y., Vilella-Bach M., Bachmann R., et al. Phosphatidic acid-mediated mitogenic activation of mTOR signaling. Science 2001, 294:1942.
74. Sato T., Nakashima A., Guo L., et al. Specific activation of mTORC1 by Rheb G-protein in vitro involves enhanced recruitment of its substrate protein. J Biol Chem 2009, 284:12783.
75. Toschi A., Lee E., Xu L., et al. Regulation of mTORC1 and mTORC2 complex assembly by phosphatidic acid: competition with rapamycin. Mol Cell Biol 2009, 29:1411.
76. Dennis M.D., Baum J.I., Kimball S.R., et al. Mechanisms involved in the coordinate regulation of the mammalian target of rapamycin complex 1 (mTORC1) by insulin and amino acids. J Biol Chem 2011, 286(10):8287-8296.
77. Drummond M.J., Bell J.A., Fujita S., et al. Amino acids are necessary for the insulin-induced activation of mTOR/S6K1 signaling and protein synthesis in healthy and insulin resistant human skeletal muscle. Clin Nutr 2008, 27:447.
78. Tipton K.D., Rasmussen B.B., Miller S.L., et al. Timing of amino acid-carbohydrate ingestion alters anabolic response of muscle to resistance exercise. Am J Physiol Endocrinol Metab 2001, 281:E197.
79. Wasa M., Wang H.S., Tazuke Y., et al. Insulin-like growth factor-I stimulates amino acid transport in a glutamine-deprived human neuroblastoma cell line. Biochim Biophys Acta 2001, 1525:118.
80. Fryburg D.A., Jahn L.A., Hill S.A., et al. Insulin and insulin-like growth factor-I enhance human skeletal muscle protein anabolism during hyperaminoacidemia by different mechanisms. J Clin Invest 1995, 96:1722.
81. Henriksen E.J., Louters L.L., Stump C.S., et al. Effects of prior exercise on the action of insulin-like growth factor I in skeletal muscle. Am J Physiol 1992, 263:E340.
82. Coletta D.K., Balas B., Chavez A.O., et al. Effect of acute physiological hyperinsulinemia on gene expression in human skeletal muscle in vivo. Am J Physiol Endocrinol Metab 2008, 294:E910.
83. Raffaello A., Milan G., Masiero E., et al. JunB transcription factor maintains skeletal muscle mass and promotes hypertrophy. J Cell Biol 2010, 191:101.
84. Trenerry M.K., Carey K.A., Ward A.C., et al. STAT3 signaling is activated in human skeletal muscle following acute resistance exercise. J Appl Physiol 2007, 102:1483.
85. Allen D.L., Unterman T.G. Regulation of myostatin expression and myoblast differentiation by FoxO and SMAD transcription factors. Am J Physiol Cell Physiol 2007, 292:C188.
86. Bark T.H., McNurlan M.A., Lang C.H., et al. Increased protein synthesis after acute IGF-I or insulin infusion is localized to muscle in mice. Am J Physiol 1998, 275:E118.
87. Stokes K.A., Sykes D., Gilbert K.L., et al. Brief, high intensity exercise alters serum ghrelin and growth hormone concentrations but not IGF-I, IGF-II or IGF-I bioactivity. Growth Horm IGF Res 2010, 20:289.
88. Nindl B.C., Pierce J.R. Insulin-like growth factor I as a biomarker of health, fitness, and training status. Med Sci Sports Exerc 2010, 42:39.
89. Heinemeier K.M., Olesen J.L., Schjerling P., et al. Short-term strength training and the expression of myostatin and IGF-I isoforms in rat muscle and tendon: differential effects of specific contraction types. J Appl Physiol 2007, 102:573.
90. Vendelbo M.H., Jorgensen J.O., Pedersen S.B., et al. Exercise and fasting activate growth hormone-dependent myocellular signal transducer and activator of transcription-5b phosphorylation and insulin-like growth factor-I messenger ribonucleic acid expression in humans. J Clin Endocrinol Metab 2010, 95:E64.
91. Berg U., Gustafsson T., Sundberg C.J., et al. Interstitial IGF-I in exercising skeletal muscle in women. Eur J Endocrinol 2007, 157:427.
92. Fedele M.J., Lang C.H., Farrell P.A. Immunization against IGF-I prevents increases in protein synthesis in diabetic rats after resistance exercise. Am J Physiol Endocrinol Metab 2001, 280:E877.
93. Spangenburg E.E., Le Roith D., Ward C.W., et al. A functional insulin-like growth factor receptor is not necessary for load-induced skeletal muscle hypertrophy. J Physiol 2008, 586:283.
94. Barton E.R., DeMeo J., Lei H. The insulin-like growth factor (IGF)-I E-peptides are required for isoform-specific gene expression and muscle hypertrophy after local IGF-I production. J Appl Physiol 2010, 108:1069.
95. Hornberger T.A., Armstrong D.D., Koh T.J., et al. Intracellular signaling specificity in response to uniaxial vs. multiaxial stretch: implications for mechanotransduction. Am J Physiol Cell Physiol 2005, 288:C185.
96. West D.W., Burd N.A., Staples A.W., et al. Human exercise-mediated skeletal muscle hypertrophy is an intrinsic process. Int J Biochem Cell Biol 2010, 42:1371.
97. Witkowski S., Lovering R.M., Spangenburg E.E. High-frequency electrically stimulated skeletal muscle contractions increase p70s6k phosphorylation independent of known IGF-I sensitive signaling pathways. FEBS Lett 2010, 584:2891.
98. Vaitheesvaran B., LeRoith D., Kurland I.J. MKR mice have increased dynamic glucose disposal despite metabolic inflexibility, and hepatic and peripheral insulin insensitivity. Diabetologia 2010, 53:2224.
99. Fernandez A.M., Dupont J., Farrar R.P., et al. Muscle-specific inactivation of the IGF-I receptor induces compensatory hyperplasia in skeletal muscle. J Clin Invest 2002, 109:347.
100. Serra C., Bhasin S., Tangherlini F., et al. The role of GH and IGF-I in mediating anabolic effects of testosterone on androgen-responsive muscle. Endocrinology 2011, 152:193.
101. Schiaffino S., Mammucari C. Regulation of skeletal muscle growth by the IGF1-Akt/PKB pathway: insights from genetic models. Skelet Muscle 2011, 1:4.
102. Perrault R., Wright B., Storie B., et al. Tyrosine kinase-independent activation of extracellular-regulated kinase (ERK) 1/2 by the insulin-like growth factor-1 receptor. Cell Signal 2011, 23(4):739-746.
103. Saegusa J., Yamaji S., Ieguchi K., et al. The direct binding of insulin-like growth factor-1 (IGF-1) to integrin alphavbeta3 is involved in IGF-1 signaling. J Biol Chem 2009, 284:24106.
104. Winter J.N., Fox T.E., Kester M., et al. Phosphatidic acid mediates activation of mTORC1 through the ERK signaling pathway. Am J Physiol Cell Physiol 2010, 299:C335.
105. Sarbassov D.D., Jones L.G., Peterson C.A. Extracellular signal-regulated kinase-1 and -2 respond differently to mitogenic and differentiative signaling pathways in myoblasts. Mol Endocrinol 1997, 11:2038.
106. Lee S.J., McPherron A.C. Regulation of myostatin activity and muscle growth. Proc Natl Acad Sci U S A 2001, 98:9306.
107. Kalista S., Schakman O., Gilson H., et al. The type 1 insulin-like growth factor receptor (IGF-IR) pathway is mandatory for the follistatin-induced skeletal muscle hypertrophy. Endocrinology 2012, 153:241.
108. Gilson H., Schakman O., Kalista S., et al. Follistatin induces muscle hypertrophy through satellite cell proliferation and inhibition of both myostatin and activin. Am J Physiol Endocrinol Metab 2009, 297:E157.
109. Qaisar R., Renaud G., Morine K., et al. Is functional hypertrophy and specific force coupled with the addition of myonuclei at the single muscle fiber level?. FASEB J 2012, 26:1077.
110. Kota J., Handy C.R., Haidet A.M., et al. Follistatin gene delivery enhances muscle growth and strength in nonhuman primates. Sci Transl Med 2009, 1:6ra15.
111. Goodman C.A., Mayhew D.L., Hornberger T.A. Recent progress toward understanding the molecular mechanisms that regulate skeletal muscle mass. Cell Signal 2011, 23:1896.
112. Stewart C.E., Pell J.M. Point: Counterpoint: IGF is/is not the major physiological regulator of muscle mass. Point: IGF is the major physiological regulator of muscle mass. J Appl Physiol 2010, 108:1820.
113. Canonici A., Steelant W., Rigot V., et al. Insulin-like growth factor-I receptor, E-cadherin and alpha v integrin form a dynamic complex under the control of alpha-catenin. Int J Cancer 2008, 122:572.
114. Maile L.A., Busby W.H., Sitko K., et al. Insulin-like growth factor-I signaling in smooth muscle cells is regulated by ligand binding to the 177CYDMKTTC184 sequence of the beta3-subunit of alphaVbeta3. Mol Endocrinol 2006, 20:405.
115. Svendsen O.S., Liden A., Nedrebo T., et al. Integrin alphavbeta3 acts downstream of insulin in normalization of interstitial fluid pressure in sepsis and in cell-mediated collagen gel contraction. Am J Physiol Heart Circ Physiol 2008, 295:H555.
116. Sinanan A.C., Machell J.R., Wynne-Hughes G.T., et al. Alpha v beta 3 and alpha v beta 5 integrins and their role in muscle precursor cell adhesion. Biol Cell 2008, 100:465.
117. Furundzija V., Fritzsche J., Kaufmann J., et al. IGF-1 increases macrophage motility via PKC/p38- dependent alphavbeta3-integrin inside-out signaling. Biochem Biophys Res Commun 2010, 394:786.
118. Andersson S., D'Arcy P., Larsson O., et al. Focal adhesion kinase (FAK) activates and stabilizes IGF-1 receptor. Biochem Biophys Res Commun 2009, 387:36.
119. Zheng D., Kurenova E., Ucar D., et al. Targeting of the protein interaction site between FAK and IGF-1R. Biochem Biophys Res Commun 2009, 388:301.
120. Shavlakadze T., Chai J., Maley K., et al. A growth stimulus is needed for IGF-1 to induce skeletal muscle hypertrophy in vivo. J Cell Sci 2010, 123:960.
121. Matheny R.W., Nindl B.C., Adamo M.L. Minireview: Mechano-growth factor: a putative product of IGF-I gene expression involved in tissue repair and regeneration. Endocrinology 2010, 151:865.
122. Tsatsoulis A., Fountoulakis S. The protective role of exercise on stress system dysregulation and comorbidities. Ann N Y Acad Sci 2006, 1083:196.
123. Braith R.W., Magyari P.M., Pierce G.L., et al. Effect of resistance exercise on skeletal muscle myopathy in heart transplant recipients. Am J Cardiol 2005, 95:1192.
124. Morley J.E., Argiles J.M., Evans W.J., et al. Nutritional recommendations for the management of sarcopenia. J Am Med Dir Assoc 2010, 11:391.
125. Ahola-Erkkila S., Carroll C.J., Peltola-Mjosund K., et al. Ketogenic diet slows down mitochondrial myopathy progression in mice. Hum Mol Genet 2010, 19:1974.
126. Muscaritoli M., Costelli P., Aversa Z., et al. New strategies to overcome cancer cachexia: from molecular mechanisms to the 'Parallel Pathway'. Asia Pac J Clin Nutr 2008, 17(Suppl 1):387.
127. Hornberger T.A., Sukhija K.B., Chien S. Regulation of mTOR by mechanically induced signaling events in skeletal muscle. Cell Cycle 2006, 5:1391.
128. Sakuma K., Yamaguchi A. Molecular mechanisms in aging and current strategies to counteract sarcopenia. Curr Aging Sci 2010, 3:90.
129. Wang H., Kubica N., Ellisen L.W., et al. Dexamethasone represses signaling through the mammalian target of rapamycin in muscle cells by enhancing expression of REDD1. J Biol Chem 2006, 281:39128.
130. Corradetti M.N., Inoki K., Guan K.L. The stress-inducted proteins RTP801 and RTP801L are negative regulators of the mammalian target of rapamycin pathway. J Biol Chem 2005, 280:9769.
131. DeYoung M.P., Horak P., Sofer A., et al. Hypoxia regulates TSC1/2-mTOR signaling and tumor suppression through REDD1-mediated 14-3-3 shuttling. Genes Dev 2008, 22:239.
132. McGhee N.K., Jefferson L.S., Kimball S.R. Elevated corticosterone associated with food deprivation upregulates expression in rat skeletal muscle of the mTORC1 repressor, REDD1. J Nutr 2009, 139:828.
133. Lang C.H., Frost R.A., Vary T.C. Acute alcohol intoxication increases REDD1 in skeletal muscle. Alcohol Clin Exp Res 2008, 32:796.
134. Murakami T., Hasegawa K., Yoshinaga M. Rapid induction of REDD1 expression by endurance exercise in rat skeletal muscle. Biochem Biophys Res Commun 2011, 405:615.
135. Kumari R., Willing L.B., Jefferson L.S., et al. REDD1 (regulated in development and DNA damage response 1) expression in skeletal muscle as a surrogate biomarker of the efficiency of glucocorticoid receptor blockade. Biochem Biophys Res Commun 2011, 412:644.
136. Frost R.A., Huber D., Pruznak A., et al. Regulation of REDD1 by insulin-like growth factor-I in skeletal muscle and myotubes. J Cell Biochem 2009, 108:1192.
137. Regazzetti C., Bost F., Le Marchand-Brustel Y., et al. Insulin induces REDD1 expression through hypoxia-inducible factor 1 activation in adipocytes. J Biol Chem 2010, 285:5157.
138. Horak P., Crawford A.R., Vadysirisack D.D., et al. Negative feedback control of HIF-1 through REDD1-regulated ROS suppresses tumorigenesis. Proc Natl Acad Sci U S A 2010, 107:4675.
139. Ellisen L.W., Ramsayer K.D., Johannessen C.M., et al. REDD1, a developmentally regulated transcriptional target of p63 and p53, links p63 to regulation of reactive oxygen species. Mol Cell 2002, 10:995.
140. Orzechowski A., Ostaszewski P., Wilczak J., et al. Rats with a glucocorticoid-induced catabolic state show symptoms of oxidative stress and spleen atrophy: the effects of age and recovery. J Vet Med A Physiol Pathol Clin Med 2002, 49:256.
141. Handayaningsih A.E., Iguchi G., Fukuoka H., et al. Reactive oxygen species play an essential role in IGF-I signaling and IGF-I-induced myocyte hypertrophy in C2C12 myocytes. Endocrinology 2011, 152(3):912-921.
142. Frost R.A., Pereyra E., Lang C.H. Ethyl pyruvate preserves IGF-I sensitivity toward mTOR substrates and protein synthesis in C2C12 myotubes. Endocrinology 2011, 152:151.
143. Shimizu N., Yoshikawa N., Ito N., et al. Crosstalk between glucocorticoid receptor and nutritional sensor mTOR in skeletal muscle. Cell Metab 2011, 13:170.
144. Fielitz J., Kim M.S., Shelton J.M., et al. Myosin accumulation and striated muscle myopathy result from the loss of muscle RING finger 1 and 3. J Clin Invest 2007, 117:2486.
145. Clarke B.A., Drujan D., Willis M.S., et al. The E3 ligase MuRF1 degrades myosin heavy chain protein in dexamethasone-treated skeletal muscle. Cell Metab 2007, 6:376.
146. Cohen S., Brault J.J., Gygi S.P., et al. During muscle atrophy, thick, but not thin, filament components are degraded by MuRF1-dependent ubiquitylation. J Cell Biol 2009, 185:1083.
147. Waddell D.S., Baehr L.M., van den Brandt J., et al. The glucocorticoid receptor and FOXO1 synergistically activate the skeletal muscle atrophy-associated MuRF1 gene. Am J Physiol Endocrinol Metab 2008, 295:E785.
148. Liu Y., Dentin R., Chen D., et al. A fasting inducible switch modulates gluconeogenesis via activator/coactivator exchange. Nature 2008, 456:269.
149. Zhao J., Brault J.J., Schild A., et al. Coordinate activation of autophagy and the proteasome pathway by FoxO transcription factor. Autophagy 2008, 4:378.
150. Demontis F., Perrimon N. FOXO/4E-BP signaling in Drosophila muscles regulates organism-wide proteostasis during aging. Cell 2010, 143:813.
151. Teleman A.A., Chen Y.W., Cohen S.M. 4E-BP functions as a metabolic brake used under stress conditions but not during normal growth. Genes Dev 2005, 19:1844.
152. Chiba T., Kamei Y., Shimizu T., et al. Overexpression of FOXO1 in skeletal muscle does not alter longevity in mice. Mech Ageing Dev 2009, 130:420.
153. Zhang D., Contu R., Latronico M.V., et al. MTORC1 regulates cardiac function and myocyte survival through 4E-BP1 inhibition in mice. J Clin Invest 2010, 120:2805.
154. Goodman C.A., Mabrey D.M., Frey J.W., et al. Novel insights into the regulation of skeletal muscle protein synthesis as revealed by a new nonradioactive in vivo technique. FASEB J 2011, 25:1028.
155. Shah O.J., Anthony J.C., Kimball S.R., et al. Glucocorticoids oppose translational control by leucine in skeletal muscle. Am J Physiol Endocrinol Metab 2000, 279:E1185.
156. Schakman O., Gilson H., de Coninck V., et al. Insulin-like growth factor-I gene transfer by electroporation prevents skeletal muscle atrophy in glucocorticoid-treated rats. Endocrinology 2005, 146:1789.
157. Lang C.H., Lynch C.J., Vary T.C. BCATm deficiency ameliorates endotoxin-induced decrease in muscle protein synthesis and improves survival in septic mice. Am J Physiol Regul Integr Comp Physiol 2010, 299:R935.
158. Wu Y., Zhao W., Zhao J., et al. REDD1 is a major target of testosterone action in preventing dexamethasone-induced muscle loss. Endocrinology 2010, 151:1050.
159. Qin W., Pan J., Wu Y., et al. Protection against dexamethasone-induced muscle atrophy is related to modulation by testosterone of FOXO1 and PGC-1alpha. Biochem Biophys Res Commun 2010, 403:473.
160. Snyder P.J., Peachey H., Hannoush P., et al. Effect of testosterone treatment on body composition and muscle strength in men over 65 years of age. J Clin Endocrinol Metab 1999, 84:2647.
161. Verdijk L.B., Snijders T., Beelen M., et al. Characteristics of muscle fiber type are predictive of skeletal muscle mass and strength in elderly men. J Am Geriatr Soc 2010, 58:2069.
162. Perrini S., Laviola L., Carreira M.C., et al. The GH/IGF1 axis and signaling pathways in the muscle and bone: mechanisms underlying age-related skeletal muscle wasting and osteoporosis. J Endocrinol 2010, 205:201.
163. West D.W., Phillips S.M. Anabolic processes in human skeletal muscle: restoring the identities of growth hormone and testosterone. Phys Sportsmed 2010, 38:97.
164. Thomas D.R. Sarcopenia. Clin Geriatr Med 2010, 26:331.
165. Bhasin S., Woodhouse L., Casaburi R., et al. Older men are as responsive as young men to the anabolic effects of graded doses of testosterone on the skeletal muscle. J Clin Endocrinol Metab 2005, 90:678.
166. Zitzmann M. Testosterone deficiency, insulin resistance and the metabolic syndrome. Nat Rev Endocrinol 2009, 5:673.
167. Jiao Q., Pruznak A.M., Huber D., et al. Castration differentially alters basal and leucine-stimulated tissue protein synthesis in skeletal muscle and adipose tissue. Am J Physiol Endocrinol Metab 2009, 297(5):E1222-E1232.
168. Pennings B., Koopman R., Beelen M., et al. Exercising before protein intake allows for greater use of dietary protein-derived amino acids for de novo muscle protein synthesis in both young and elderly men. Am J Clin Nutr 2011, 93:322.
169. Johansen J.A., Breedlove S.M., Jordan C.L. Androgen receptor expression in the levator ani muscle of male mice. J Neuroendocrinol 2007, 19:823.
170. Sato K., Iemitsu M., Aizawa K., et al. Testosterone and DHEA activate the glucose metabolism-related signaling pathway in skeletal muscle. Am J Physiol Endocrinol Metab 2008, 294:E961.
171. Aizawa K., Iemitsu M., Maeda S., et al. Acute exercise activates local bioactive androgen metabolism in skeletal muscle. Steroids 2010, 75:219.
172. Borst S.E., Lee J.H., Conover C.F. Inhibition of 5alpha-reductase blocks prostate effects of testosterone without blocking anabolic effects. Am J Physiol Endocrinol Metab 2005, 288:E222.
173. MacLean H.E., Chiu W.S., Notini A.J., et al. Impaired skeletal muscle development and function in male, but not female, genomic androgen receptor knockout mice. FASEB J 2008, 22:2676.
174. Chambon C., Duteil D., Vignaud A., et al. Myocytic androgen receptor controls the strength but not the mass of limb muscles. Proc Natl Acad Sci U S A 2010, 107:14327.
175. Klover P., Chen W., Zhu B.M., et al. Skeletal muscle growth and fiber composition in mice are regulated through the transcription factors STAT5a/b: linking growth hormone to the androgen receptor. FASEB J 2009, 23:3140.
176. Ibebunjo C., Eash J.K., Li C., et al. Voluntary running, skeletal muscle gene expression, and signaling inversely regulated by orchidectomy and testosterone replacement. Am J Physiol Endocrinol Metab 2011, 300:E327.
177. D'Antona G., Ragni M., Cardile A., et al. Branched-chain amino acid supplementation promotes survival and supports cardiac and skeletal muscle mitochondrial biogenesis in middle-aged mice. Cell Metab 2010, 12:362.
178. Honjoh S., Yamamoto T., Uno M., et al. Signalling through RHEB-1 mediates intermittent fasting-induced longevity in C. elegans. Nature 2009, 457:726.
179. Szulc P., Duboeuf F., Marchand F., et al. Hormonal and lifestyle determinants of appendicular skeletal muscle mass in men: the MINOS study. Am J Clin Nutr 2004, 80:496.
180. Raskin K., de Gendt K., Duittoz A., et al. Conditional inactivation of androgen receptor gene in the nervous system: effects on male behavioral and neuroendocrine responses. J Neurosci 2009, 29:4461.
181. Miyamoto J., Matsumoto T., Shiina H., et al. The pituitary function of androgen receptor constitutes a glucocorticoid production circuit. Mol Cell Biol 2007, 27:4807.
182. Jones A., Hwang D.J., Narayanan R., et al. Effects of a novel selective androgen receptor modulator on dexamethasone-induced and hypogonadism-induced muscle atrophy. Endocrinology 2010, 151:3706.
183. Belavy D.L., Miokovic T., Armbrecht G., et al. Differential atrophy of the lower-limb musculature during prolonged bed-rest. Eur J Appl Physiol 2009, 107:489.
184. Murton A.J., Greenhaff P.L. Muscle atrophy in immobilization and senescence in humans. Curr Opin Neurol 2009, 22:500.
185. Stein T.P., Donaldson M.R., Leskiw M.J., et al. Branched-chain amino acid supplementation during bed rest: effect on recovery. J Appl Physiol 2003, 94:1345.
186. Brooks N., Cloutier G.J., Cadena S.M., et al. Resistance training and timed essential amino acids protect against the loss of muscle mass and strength during 28 days of bed rest and energy deficit. J Appl Physiol 2008, 105:241.
187. Brooks N.E., Cadena S.M., Vannier E., et al. Effects of resistance exercise combined with essential amino acid supplementation and energy deficit on markers of skeletal muscle atrophy and regeneration during bed rest and active recovery. Muscle Nerve 2010, 42:927.
188. Alzghoul M.B., Gerrard D., Watkins B.A., et al. Ectopic expression of IGF-I and Shh by skeletal muscle inhibits disuse-mediated skeletal muscle atrophy and bone osteopenia in vivo. FASEB J 2004, 18:221.
189. Cai D., Frantz J.D., Tawa N.E., et al. IKKbeta/NF-kappaB activation causes severe muscle wasting in mice. Cell 2004, 119:285.
190. Sandri M., Sandri C., Gilbert A., et al. Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy. Cell 2004, 117:399.
191. Buford T.W., Cooke M.B., Manini T.M., et al. Effects of age and sedentary lifestyle on skeletal muscle NF-kappaB signaling in men. J Gerontol A Biol Sci Med Sci 2010, 65:532.
192. Reed S.A., Senf S.M., Cornwell E.W., et al. Inhibition of IkappaB kinase alpha (IKKα) or IKKbeta (IKKβ) plus forkhead box O (Foxo) abolishes skeletal muscle atrophy. Biochem Biophys Res Commun 2011, 405:491.
193. Dodd S.L., Gagnon B.J., Senf S.M., et al. Ros-mediated activation of NF-kappaB and Foxo during muscle disuse. Muscle Nerve 2010, 41:110.
194. Reid M.B. Free radicals and muscle fatigue: of ROS, canaries, and the IOC. Free Radic Biol Med 2008, 44:169.
195. Arbogast S., Smith J., Matuszczak Y., et al. Bowman-Birk inhibitor concentrate prevents atrophy, weakness, and oxidative stress in soleus muscle of hindlimb-unloaded mice. J Appl Physiol 2007, 102:956.
196. Selsby J.T., Rother S., Tsuda S., et al. Intermittent hyperthermia enhances skeletal muscle regrowth and attenuates oxidative damage following reloading. J Appl Physiol 2007, 102:1702.
197. Selsby J.T., Dodd S.L. Heat treatment reduces oxidative stress and protects muscle mass during immobilization. Am J Physiol Regul Integr Comp Physiol 2005, 289:R134.
198. Kakigi R., Naito H., Ogura Y., et al. Heat stress enhances mTOR signaling after resistance exercise in human skeletal muscle. J Physiol Sci 2011, 61:131.
199. Chen Y.W., Gregory C.M., Scarborough M.T., et al. Transcriptional pathways associated with skeletal muscle disuse atrophy in humans. Physiol Genomics 2007, 31:510.
200. Stevens-Lapsley J.E., Ye F., Liu M., et al. Impact of viral-mediated IGF-I gene transfer on skeletal muscle following cast immobilization. Am J Physiol Endocrinol Metab 2010, 299:E730.
201. Criswell D.S., Booth F.W., DeMayo F., et al. Overexpression of IGF-I in skeletal muscle of transgenic mice does not prevent unloading-induced atrophy. Am J Physiol 1998, 275:E373.
202. Merezhinskaya N., Fishbein W.N., Davis J.I., et al. Mutations in MCT1 cDNA in patients with symptomatic deficiency in lactate transport. Muscle Nerve 2000, 23:90.
203. Evans K., Nasim Z., Brown J., et al. Acidosis-sensing glutamine pump SNAT2 determines amino acid levels and mammalian target of rapamycin signalling to protein synthesis in L6 muscle cells. J Am Soc Nephrol 2007, 18:1426.
204. Chambard J.C., Pouyssegur J. Intracellular pH controls growth factor-induced ribosomal protein S6 phosphorylation and protein synthesis in the G0-G1 transition of fibroblasts. Exp Cell Res 1986, 164:282.
205. Woods D.J., Soden J., Tomlinson S., et al. Transmembrane Na+/H+ exchange in the rat thyroid cell strain FRTL-5: a possible role in insulin-like growth factor-I-mediated proliferation. J Mol Endocrinol 1990, 4:177.
206. Fernandez-Sola J., Preedy V.R., Lang C.H., et al. Molecular and cellular events in alcohol-induced muscle disease. Alcohol Clin Exp Res 2007, 31:1953.
207. Lang C.H., Kimball S.R., Frost R.A., et al. Alcohol myopathy: impairment of protein synthesis and translation initiation. Int J Biochem Cell Biol 2001, 33:457.
208. Kumar V., Frost R.A., Lang C.H. Alcohol impairs insulin and IGF-I stimulation of S6K1 but not 4E-BP1 in skeletal muscle. Am J Physiol Endocrinol Metab 2002, 283:E917.
209. Lang C.H., Fan J., Lipton B.P., et al. Modulation of the insulin-like growth factor system by chronic alcohol feeding. Alcohol Clin Exp Res 1998, 22:823.
210. Lang C.H., Frost R.A., Svanberg E., et al. IGF-I/IGFBP-3 ameliorates alterations in protein synthesis, eIF4E availability, and myostatin in alcohol-fed rats. Am J Physiol Endocrinol Metab 2004, 286:E916.
211. Lang C.H., Frost R.A., Deshpande N., et al. Alcohol impairs leucine-mediated phosphorylation of 4EBP1, S6K1, eIF4G, and mTOR in skeletal muscle. Am J Physiol Endocrinol Metab 2003, 285:E1205.
212. Lang C.H., Frost R.A., Vary T.C. Skeletal muscle protein synthesis and degradation exhibit sexual dimorphism after chronic alcohol consumption but not acute intoxication. Am J Physiol Endocrinol Metab 2007, 292:E1497.
213. Vargas R., Lang C.H. Alcohol accelerates loss of muscle and impairs recovery of muscle mass resulting from disuse atrophy. Alcohol Clin Exp Res 2008, 32:128.
214. Lang C.H., Lynch C.J., Vary T.C. Alcohol-induced IGF-I resistance is ameliorated in mice deficient for mitochondrial branched-chain aminotransferase. J Nutr 2010, 140:932.
215. Sun X., Zemel M.B. Leucine modulation of mitochondrial mass and oxygen consumption in skeletal muscle cells and adipocytes. Nutr Metab (Lond) 2009, 6:26.
216. Du M., Shen Q.W., Zhu M.J., et al. Leucine stimulates mammalian target of rapamycin signaling in C2C12 myoblasts in part through inhibition of adenosine monophosphate-activated protein kinase. J Anim Sci 2007, 85:919.
217. Hong-Brown L.Q., Brown C.R., Navaratnarajah M., et al. Alcohol-induced modulation of rictor and mTORC2 activity in C2C12 myoblasts. Alcohol Clin Exp Res 1445, 35.
218. Hong-Brown L.Q., Brown C.R., Kazi A.A., et al. Rag GTPases and AMPK/TSC2/Rheb mediate the differential regulation of mTORC1 signaling in response to alcohol and leucine. Am J Physiol Cell Physiol 2012, [Epub ahead of print].